Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.446 | Validation of 3D Reconstruction Algorithm and Automated Measurements of 3D Spinal Images Bases on Posteroanterior and Lateral Radiographs on Children with Adolescent Idiopathic Scoliosis | Prof. CHU Winnie Chiu-wing |
| 2024.445 | The effect of medication reconciliation and discharge counseling by ward pharmacists on 30-day readmission rate: A Retrospective Study at Prince of Wales Hospital | Ms. IP Wing Tung |
| 2024.444 | Real-world survival and characteristics of patients with metastatic ALK-rearranged non–small cell lung cancer in Hong Kong |
Dr. LEUNG Ho Yan 梁浩恩 |
| 2024.443 | Targeting chromosome 8 open reading frame 76 (C8orf76) in boosting immunotherapy in colorectal cancer: molecular mechanism and potential clinical application | Prof. GOU Hongyan |
| 2024.441 | A Phase 2, Open-label Study Evaluating STRO-002, an Anti-folate Receptor Alpha (FOLR1) Antibody-Drug Conjugate, in Subjects with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer Expressing FOLR1 | Dr. LOONG Herbert Ho Fung |
| 2024.440 | A Phase III double-blind, randomised, placebo-controlled trial to evaluate liver-related clinical outcomes and safety of once weekly injected survodutide in participants with compensated non-alcoholic steatohepatitis/metabolic dysfunction associated steatohepatitis (NASH/MASH) cirrhosis |
Prof. WONG Vincent Wai Sun Wai Sun Vincent Wong |
| 2024.439 | A Validation Study of the Hong Kong Version of the Personal Impact of Epilepsy Scale (HK-PIES) for People with Epilepsy in Hong Kong | Dr. CHAN Cheuk Him Charlie |
| 2024.438 | Re-Defining Standard of Care – Heart Failure and Fluid Assessment | Dr. KAM Kevin Ka Ho |
| 2024.437 | Review of non-nasopharyngeal lymphoepithelial carcinoma in the head and neck | Dr. LEUNG Ho Sang |
| 2024.436 | Outcomes of Conversion Gastrectomy in Metastatic Gastric Cancer |
Dr. CHAN Shannon Melissa 陳詩瓏 |
| 2024.435 | Treatment, Disabilities and Cost-effectiveness Analysis of von Hippel-Lindau Syndrome Patients – A Retrospective Cohort Study | Dr. LEUNG Ka Wai |
| 2024.434 | The fifth INTEnsive pReventing secondary injury in Acute Cerebral haemorrhage Trial (INTERACT5) |
Professor Leung Thomas Wai Hong 梁慧康 |
| 2024.433 | Evaluation of innovative school-based interventions on health outcomes among primary school students during post COVID-19 pandemic |
Prof. LAU Ying 劉櫻 |
| 2024.432 | Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial carcinoma-A pilot study | Prof. TEOH Yuen Chun |
| 2024.431 | Hybrid cohort and case-control study on male urinary HPV in selected groups | Dr. TEOH Jeremy Yuen Chun |
| 2024.430 | Cardio- and Cerebrovascular Disease Biobank for Research | Dr. IP Bonaventure Yiu Ming |
| 2024.429 | A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN) | Prof. SZETO Cheuk Chun |
| 2024.428 | The disease burden of RSV infection in Hong Kong | Prof. HUI David Shu Cheong |
| 2024.427 | Risk factors associated with Multi-drug resistant organisms (MDRO) carrier status in three Residential Care Homes for the Elderly (RCHE) in Tai Po district | Dr LEUNG Stephanie Siu Tung |
| 2024.426 | The association of refractive error and deviation control of patients with intermittent exotropia in Hong Kong | Mr. YAU Tsz Him |
| 2024.425 | An Open-Label, Multicenter, Phase 1 Study of AN4005 in Patients with Advanced Tumors | Dr. LOONG Herbert Ho Fung |
| 2024.424 | Risk stratification of acid suppressant-related major adverse events in Asians: a retrospective cohort study | Prof. HUANG Junjie |
| 2024.423 | Utilisation of Big Data Analytics to Enhance Survival for Patients Living with Cancers | Prof. HUANG Junjie |
| 2024.421 | Validation of a breath-based test in predicting response of carvedilol in patients with compensated advanced chronic liver disease |
Dr. LAI Jimmy Che To Grace LH Wong |
| 2024.419 | Dysarthric Speech Pattern Detection, Analysis and Reconstruction for Rehabilitation Training |
Prof. MENG Mei-Ling, Helen 蒙美玲 |
| 2024.418 | An evaluation of the effectiveness and cost-effectiveness of the Chronic Disease Co-Care (CDCC) Pilot Scheme: a commissioned study | Dr Leung Shuk Yun |
| 2024.417 | Assessing Cancer Risk and Comorbidities in Diabetic vs. Non-Diabetic Patients in Hong Kong: a retrospective cohort study | Prof. HUANG Junjie |
| 2024.416 | Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design | Professor Lau Ying |
| 2024.415 | Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design |
Ms. CHUNG Yuen Man Josephine 鐘婉雯 |
| 2024.414 | Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design |
Ms. SHIU Irene Yuk Chun 蕭玉珍 |
| 2024.413 | Analysis of Time to diagnosis & Outcomes of Primary Hyperparathyroidism in adults in a local hospital | Dr. LAM Long Yi |
| 2024.412 | Comparison of Acute Kidney Injury Risk Prediction Scores after Aortic and Cardiac Surgery | Dr. LEE Christopher P.T. |
| 2024.411 | Effect of feedback devices on chest compression quality in Hong Kong nurses: A cross-over manikin study |
Mr. LEE Wai Yat 李瑋日 |
| 2024.410 | Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial |
Prof. POON Eric Tsz Chun Eric Tsz-chun Poon |
| 2024.409 | A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy | Prof. YEO Winnie |
| 2024.408 | Preoperative continuous PENG block for geriatric hip fracture patients: a pilot feasibility study | Dr. TENG Irving |
| 2024.407 | Measuring the neural markers of hearing and spatial hearing in normal hearing and hearing impaired using functional near-infrared spectroscopy and electroencephalography | Dr. SCHNUPP Jan |
| 2024.406 | Hong Kong old age home nurses’ attitudes and knowledge toward advance directive | Mr. TSE Tsz Tsun |
| 2024.405 | FOXC1 regulatory network in trastuzumab resistance of HER2+ breast cancer and potential clinical values |
Dr. TSE Gary Man-Kit 謝文杰 |
| 2024.404 | Outcome prediction of breast cancer patients with neoadjuvant therapy |
Prof. TSE Gary Man Kit 謝文杰 |
| 2024.403 | Functional characterization of a novel 19q13 KRAB-zinc-finger repressor in regulating cancer stemness and metastasis of esophageal cancer | Professor Tao Qian |
| 2024.402 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Povetacicept in Adults with Immunoglobulin A Nephropathy (RAINIER) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.401 | Evaluating a novel, allosteric glucokinase activator in monogenic diabetes secondary to inactivating glucokinase mutations: a randomised, cross-over trial | Dr. CHOW Elaine |
| 2024.400 | Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial with a Historical Control Group | Prof. LEUNG Thomas Wai Hong |
| 2024.399 | Combined Leadless Pacemaker and Left Atrial Appendage Occlusion Registry |
Prof. Tam Tsz Kin 譚子健 |
| 2024.398 | Adjunctive Fludrocortisone in Septic Shock: a multicenter, double-blind, randomized, placebo-controlled pilot trial (AFLUDROS-1) | Dr LING Lowell |
| 2024.397 | Beamion LUNG-2: A Phase III, open-label, randomized, active-controlled, multi-centre trial evaluating orally administered zongertinib (BI 1810631) compared with standard of care as first-line treatment in patients with unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer harbouring HER2 tyrosine kinase domain mutations | Dr. LOONG Herbert Ho Fung |
| 2024.396 | Integrative machine learning analysis of gut microbiome for predicting conversion from mild cognitive impairment to dementia | Dr. LEE Allen Ting Chun |
| 2024.395 | Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia |
Dr. YIP Hon Chi 葉瀚智 |
| 2024.394 | Mycophenolate mofetil in Chinese patients with immune thrombocytopenia | Dr. WONG Raymond |
Page 14 of 267.